HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sinus bradycardia induced by talipexole hydrochloride in a patient with Parkinson disease].

Abstract
We report sinus bradycardia induced by talipexole hydrochloride in a 65-year-old man with Parkinson disease. Approximately four hours after he had taken 0.8 mg of talipexole hydrochloride, he acutely developed sleepiness, delusion, akinesia, and faintness associated with hypotension and sinus bradycardia. Another similar episode occurred when he had taken talipexole hydrochloride 1.2 mg/day in combination with a daily dose of 200 mg of levodopa and 20 mg of carbidopa. These symptoms persisted for 12 hours and diminished gradually without any specific treatments. Talipexole hydrochloride, a stimulator of both the D2 and alpha 2 receptors probably induced bradycardia and hypotension in the present case.
AuthorsT Sakai, Y Ii, S Kuzuhara
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 38 Issue 8 Pg. 771-5 (Aug 1998) ISSN: 0009-918X [Print] Japan
PMID9916527 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Azepines
  • Dopamine Agonists
  • talipexole
Topics
  • Acute Disease
  • Aged
  • Arrhythmia, Sinus (chemically induced)
  • Azepines (adverse effects)
  • Bradycardia (chemically induced)
  • Dopamine Agonists (adverse effects)
  • Humans
  • Male
  • Parkinson Disease (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: